Adaptive Biotechnologies Files 2024 Annual Report
Ticker: ADPT · Form: 10-K · Filed: Mar 3, 2025 · CIK: 1478320
| Field | Detail |
|---|---|
| Company | Adaptive Biotechnologies Corp (ADPT) |
| Form Type | 10-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology
TL;DR
ADPT filed its 2024 10-K. All systems go for the biotech.
AI Summary
Adaptive Biotechnologies Corp. filed its 2024 10-K on March 3, 2025, detailing its fiscal year ending December 31, 2024. The company, incorporated in Washington, operates in the biological products sector. Key financial information and operational details for the period are presented in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Adaptive Biotechnologies' financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, Adaptive Biotechnologies faces inherent risks related to research and development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-03 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Adaptive Biotechnologies Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-03 (date) — Filing date
- Seattle, WA (location) — Company headquarters
- Genentech (company) — Collaboration agreement
FAQ
What is the primary business of Adaptive Biotechnologies Corp. as described in the filing?
The company is involved in biological products, specifically excluding diagnostic substances, as indicated by its SIC code [2836].
When did Adaptive Biotechnologies Corp. change its name from Adaptive TCR Corp?
The company's name changed from Adaptive TCR Corp on December 9, 2009.
What is the business address of Adaptive Biotechnologies Corp.?
The business address is 1165 Eastlake Ave E, Seattle, WA 98109.
What is the SEC file number for Adaptive Biotechnologies Corp.?
The SEC file number is 001-38957.
Does the filing mention any specific collaboration agreements?
Yes, the filing references the 'Genentech Collaboration Agreement'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 3, 2025 regarding Adaptive Biotechnologies Corp (ADPT).